Status:
COMPLETED
Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel
Lead Sponsor:
Sara Botros
Conditions:
Tinea Versicolor
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Clinical study for the developed Itraconazole self nano emulsifying drug delivery system intermediate gel was conducted on 30 patients with tinea versicolor infection.
Detailed Description
The clinical work has been carried out in accordance with The Code of Ethics of the World Medical Association for experiments involving humans. The study was conducted on 30 patients (10 to 60 years o...
Eligibility Criteria
Inclusion
- Tinea Versicolor infection
Exclusion
- concomitant treatment with other medications for the same condition being studied, TVC.
- pregnancy
- lactation
- immunocompromised patients
Key Trial Info
Start Date :
February 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04110834
Start Date
February 15 2018
End Date
June 30 2018
Last Update
October 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minia University hospital
Minya, Minya Governorate, Egypt, 61519